Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1376 of 6351
-
New pill aims to slow vision loss in dry AMD
Disease control Not yet recruitingThis is a parallel, randomized, open-label, controlled study to evaluate the efficacy and safety of oral EG-301 in patients with intermediate non-exudative (dry) age-related macular degeneration (dAMD). Ninety patients will be randomly allocated in a 2:1 ratio to one of two trea…
Phase 2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Immune cells armed with cancer-seeking antibodies tested in advanced cancers
Disease control Recruiting nowThe purpose of this study is to understand the safety and estimate the efficacy of anti-CD3 x anti-HER2 bispecific antibody (HER2Bi) armed fresh peripheral blood mononuclear cells (HER2 FPBMC) for patients with metastatic breast or prostate cancer. Participants receive 5 weekly d…
Phase 1/2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
A needle instead of a knife: new hope for breast abscess treatment
Disease control Recruiting nowBreast abscess is a localized suppurative complication of breast infection commonly managed by ultrasound-guided needle aspiration combined with antibiotic therapy. This prospective observational study aims to evaluate the clinical outcomes and prognostic factors associated with …
Sponsor: Sohag University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a simple checklist boost heart surgery recovery?
Knowledge-focused Recruiting nowThis prospective observational study will evaluate the association between compliance with an Enhanced Recovery After Surgery (ERAS) protocol and length of hospital stay in 120 adults undergoing elective open heart surgery. Secondary outcomes will include nutritional status, post…
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Sep 10, 2026 09:00 UTC
-
Could a second ultrasound spot hidden gallbladder trouble?
Diagnosis Recruiting nowThe goal of this interventional, prospective study is to determine the clinical utility of a repeat point-of-care ultrasound of the gallbladder in adult emergency department patients with abdominal pain for which initial imaging is not diagnostic. The main question it aims to ans…
Sponsor: WellSpan Health • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
Can we predict eye damage after stem cell transplants?
Knowledge-focused Recruiting nowThis study is a multicenter, prospective, observational cohort study designed to enroll a total of 340 patients undergoing allogeneic hematopoietic stem cell transplantation. Through comprehensive evaluations by hematology departments, ophthalmology departments, and patient-repor…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New pill could help dialysis patients control dangerous phosphate levels
Disease control Recruiting nowThis study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receiving maintenance hemodialysis.
Phase 2 • Sponsor: R1 Therapeutics • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can simulated High-Altitude breathing boost lung cancer treatment?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding intermittent hypoxic training (IHT) to standard neoadjuvant chemo-immunotherapy can increase the pathologic complete response (pCR) rate in patients aged 18 to 75 of both sexes with resectable stage II-IIIA lung squamous cell …
Phase 2 • Sponsor: zhang yi • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
AI-Crafted diet supplement takes on type 2 diabetes
Disease control Recruiting nowAIM-MET is a randomized clinical study testing whether a fixed microbiome-targeted nutritional product can improve blood sugar control in adults with type 2 diabetes when used in addition to usual stable diabetes treatment. The study will compare the active nutritional product w…
Sponsor: ENBIOSIS BIOTECHNOLOGIES • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could AR games beat the patch? new study tests lazy eye treatment in teens and adults
Symptom relief Not yet recruitingThe goal of this clinical trial is to investigate the efficacy and safety of dichoptic treatment based on Augmented Reality (AR) technology in treating monocular amblyopia aged 12 to 55 years, and compare dichoptic AR treatment with the standard patching therapy. The main questio…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a gut bacteria transplant ease heart failure in seniors?
Disease control Not yet recruitingThis is a single-center, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) in elderly patients with heart failure with preserved ejection fraction (HFpEF). HFpEF is a common type of heart fai…
Phase 1/2 • Sponsor: The First Affiliated Hospital of Air Force Medicial University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New ultrasound technique may predict chemo success after just one dose
Diagnosis Not yet recruiting1. Study Design Overview Study Type: Single-center, prospective, observational, diagnostic study. Primary Objective: To validate whether Super-Resolution Ultrasound Imaging (SRUS) can accurately predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in bre…
Sponsor: Anhui Provincial Cancer Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Gum disease gel could save your teeth
Disease control Not yet recruitingChronic periodontitis is one of the most prevalent inflammatory diseases affecting the tooth-supporting structures and is characterized by progressive clinical attachment loss and alveolar bone resorption resulting from a complex interaction between pathogenic microorganisms and …
Phase 4 • Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a 4-Day therapy tame OCD? new study aims to find out
Symptom relief Recruiting nowThe aim of this study is to expand access to Bergen Four-Day Treatment (B4DT) in Finland and to integrate it into psychiatric care pathways at Tampere University Hospital (TAYS). A Bergen team has been established within TAYS Psychiatry and has been trained in collaboration with …
Sponsor: Tampere University Hospital • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Inhaled therapy aims to cut lung Tumors' sugar supply
Disease control Not yet recruitingThe primary objective of this pilot study is to determine if AER101 can decrease glycolysis in non-small cell lung cancer (NSCLC). Glycolysis is the process cells use to break down sugar (glucose) into a smaller substance in the fluid part inside the cell. Many lung cancers begin…
Early phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Herbal formula plus eye injections: a new hope for blocked retinal veins?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the synergistic efficacy and safety of the Tongluo Huayu Formula combined with conventional Western medical treatment for RVO, thereby providing high-quality evidence to support its subsequent clinical promotion and application. The…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New shot could ease stuffy noses and polyps for sinusitis sufferers
Disease control Not yet recruitingThis is an open-label, single-arm, multicenter, extension study to evaluate the safety and efficacy of CM512 in patients With Chronic Rhinosinusitis with Nasal Polyposis
Phase 2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for stubborn high blood pressure? phase 3 trial launches
Disease control Not yet recruitingAprocitentan tablets are currently the only endothelin dual receptor antagonist approved internationally for the treatment of resistant hypertension.This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 study to evaluate the efficacy and safety of aprocitent…
Phase 3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug may shield heart surgery patients from deadly complications
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy and safety of perioperative vericiguat in patients undergoing cardiovascular surgery. Patients at high risk of heart failure or with confirmed cardiac dysfunction will be randomly assigned to receive either vericiguat plus sta…
Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New Long-Acting shot aims to tame acromegaly in phase 3 trial
Disease control Not yet recruitinghe purpose of this study is to evaluate the efficacy and safety of SYHX2008 injection in in patients with acromegaly.
Phase 3 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC